Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Copenhagen, January 16, 2023 Gemstone Capital will act as financial adviser to Stenocare in connection with their upcoming Units Rights Issue of up to 29.7 mDKK. Gemstone Capital is pleased to announce that it will act as financial adviser for Stenocare in their upcomming Rights Issue of Units. Stenocare is a Danish market-leading company in…
Copenhagen, January 25, 2023 Gemstone Capital A/S acted as sole financial advisor to Spermosens AB. What a breeze, that it IS possible to succeed, even in todays tough market. The ingredients: a great little company, attractive terms and a focused campaign. Now, we look forward to the commercialization of Spermosens’ technology that has the potential…
Välkommen att teckna Units i Spermosens AB Teckningstid: 9 – 23 januari 2023 Observera att vissa banker kan stänga möjligheten för teckning redan torsdagen den 19 januari 📣 Delta i en livepresentation av företaget med VD Ulrik Nilsson med möjlighet att ställa frågor i ett Teams Meeting måndag den 16:e kl 17:00, eller tisdag den…
Invitation to subscribe in Spermosens AB’s Unit Rights Issue Subscription period: 9 – 23 January 2023 Please note that certain banks may close for subscription as early as Thursday, the 19th of January 📣 Join CEO Ulrik Nilsson for a live presentation of the company with Q&A in a Teams Meeting on Monday, the 16th…
Copenhagen, August 29, 2021 What can we learn from Swedish Investors about Life Science Investments? On Monday the 29th of August our non-executive partner Stefan Lundgren presented at Økonomiske Ugebrevs Life Science Conference. In his presentation, Stefan discussed his view on the dynamics and differences between the Swedish and Danish Life Science space, based on…
Copenhagen, August 29, 2021 What can we learn from Swedish Investors about Life Science Investments? On Monday the 29th of August our non-executive partner Stefan Lundgren presented at Økonomiske Ugebrevs Life Science Conference. In his presentation, Stefan discussed his view on the dynamics and differences between the Swedish and Danish Life Science space, based on…
Copenhagen, 16 November 2021 Managing Partner Søren Jonas Bruun in the studio [03:35:50] on the status on the First North market in Copenhagen and announcing Gemstone research comparing the Danish and Swedish markets.
Copenhagen, 23 November 2020 Søren Jonas Bruun, Managing Partner i Gemstone Capital er i studiet på sammen med Michael Friis Jørgensen fra HCA Capital, Per Hansen fra Nordnet og interviewet af Mikael Bak fra Dansk Aktionærforening. Følg med fra [09:22] og hør bl.a. om hvad vi kan lære af børs-markedet i Sverige. 09.22: Nordiske fordele:…
Copenhagen, July 13, 2019Today, STENOCARE has signed a significant contract to establish a large scale, state-of-the-art medical cannabis cultivation facility in Denmark. At the same time, STENOCARE has secured 15mDKK in debt financing which in combination with cash at hand will finance the contract. Raising the bar: For more than a year, STENOCARE has been…
Copenhagen, 16 May 2019 MenuPay AB’s (publ) (“MenuPay” or the “Company”) rights issue with preferential rights for the Company’s shareholders was subscribed to 101,6% percent. The Company’s financial position was improved by a total of 23,4mSEK of which 11,4mSEK was cash subscription. After transaction cost these proceeds will be leveraged to fuel further expansion of…